Clinical Efficacy of Intravenous Immunoglobulin for BK Polyomavirus-Associated Nephropathy After Living Kidney Transplantation.
Soichi MatsumuraTaigo KatoAyumu TaniguchiMasataka KawamuraShigeaki NakazawaTomoko Namba-HamanoToyofumi AbeNorio NonomuraRyoichi ImamuraPublished in: Therapeutics and clinical risk management (2020)
Although it is difficult to treat BKPyVAN after kidney transplant, IVIG therapy was considered to a promising treatment to improve severity of BKPyVAN especially in cases that dose reduction of immunosuppressive agents was ineffective.